HK1200843A1 - 生產用於皮下使用的高度濃縮的免疫球蛋白製品的方法 - Google Patents
生產用於皮下使用的高度濃縮的免疫球蛋白製品的方法Info
- Publication number
- HK1200843A1 HK1200843A1 HK15101161.4A HK15101161A HK1200843A1 HK 1200843 A1 HK1200843 A1 HK 1200843A1 HK 15101161 A HK15101161 A HK 15101161A HK 1200843 A1 HK1200843 A1 HK 1200843A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- produce
- highly concentrated
- immunoglobulin preparation
- subcutaneous use
- concentrated immunoglobulin
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000007920 subcutaneous administration Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/16—Diafiltration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Water Supply & Treatment (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18160609P | 2009-05-27 | 2009-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1200843A1 true HK1200843A1 (zh) | 2015-08-14 |
Family
ID=42335649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15101161.4A HK1200843A1 (zh) | 2009-05-27 | 2015-02-04 | 生產用於皮下使用的高度濃縮的免疫球蛋白製品的方法 |
Country Status (18)
Country | Link |
---|---|
US (5) | US8546548B2 (zh) |
EP (3) | EP2435474A2 (zh) |
JP (1) | JP5341252B2 (zh) |
KR (1) | KR101464032B1 (zh) |
CN (1) | CN102459331B (zh) |
AR (1) | AR076607A1 (zh) |
AU (6) | AU2010253830B2 (zh) |
BR (1) | BRPI1012082B1 (zh) |
CA (1) | CA2763138A1 (zh) |
CL (2) | CL2011002996A1 (zh) |
CO (1) | CO6480954A2 (zh) |
EA (1) | EA023382B1 (zh) |
HK (1) | HK1200843A1 (zh) |
MX (1) | MX2011012576A (zh) |
MY (1) | MY157239A (zh) |
SG (1) | SG176256A1 (zh) |
TW (1) | TWI445714B (zh) |
WO (1) | WO2010138736A2 (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI489994B (zh) | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
EP2435474A2 (en) * | 2009-05-27 | 2012-04-04 | Baxter International Inc | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
ES2662529T3 (es) | 2009-08-06 | 2018-04-06 | F. Hoffmann-La Roche Ag | Procedimiento para mejorar la eliminación de virus en la purificación de proteínas |
MX2012003282A (es) * | 2009-09-17 | 2012-04-30 | Baxter Healthcare Sa | Co-formulacion estable de hialuronidasa e inmunoglobulina, y metodos de su uso. |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
FR2962650B1 (fr) * | 2010-07-19 | 2013-04-05 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
EA027353B1 (ru) | 2010-09-17 | 2017-07-31 | Баксалта Инкорпорейтид | СТАБИЛИЗАЦИЯ ИММУНОГЛОБУЛИНОВ С ПОМОЩЬЮ ВОДНОГО СОСТАВА С ГИСТИДИНОМ ПРИ pH ОТ СЛАБОКИСЛОГО ДО НЕЙТРАЛЬНОГО |
FR2974301B1 (fr) | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
FR2977893B1 (fr) * | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
CA2846599A1 (en) | 2011-08-26 | 2013-03-07 | Baxter International Inc. | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
AU2012311483B2 (en) | 2011-09-24 | 2016-03-10 | Csl Behring Gmbh | Combination therapy using immunoglobulin and C1-inhibitor |
KR20140104479A (ko) | 2011-12-13 | 2014-08-28 | 백스터 인터내셔널 인코포레이티드 | 민감도가 증가된 저전도율 조건에서의 자가항체의 측정 |
CN102532307B (zh) * | 2012-02-22 | 2013-06-12 | 成都蓉生药业有限责任公司 | 一种制备人免疫球蛋白的方法 |
TWI629283B (zh) * | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
JP6224586B2 (ja) * | 2012-07-10 | 2017-11-01 | 武田薬品工業株式会社 | 注射用製剤 |
KR102403299B1 (ko) | 2013-03-08 | 2022-06-03 | 체에스엘 베링 게엠베하 | 원격 허혈-재관류 손상의 치료 및 예방 |
AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
MX2016006167A (es) * | 2013-11-15 | 2016-08-08 | Genentech Inc | Metodos para la inactivacion viral usando detergentes ecologico. |
US20160287634A1 (en) * | 2015-04-02 | 2016-10-06 | Kieu Hoang | Method of manufacturing an afod intravenous injection from fraction iv to prevent and kill hiv-1 and hiv-2 |
WO2016196070A1 (en) | 2015-06-03 | 2016-12-08 | Children's Hospital Medical Center | Compositions and methods for treating neonatal biliary atresia |
US11186858B1 (en) | 2016-03-15 | 2021-11-30 | Fresenius Kabi Deutschland Gmbh | Methods for increasing biosimilarity |
EP3275897A1 (en) * | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
FR3081328B1 (fr) * | 2018-05-24 | 2021-01-01 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
KR102337683B1 (ko) * | 2018-09-21 | 2021-12-13 | 주식회사 녹십자 | 고효율 항-tfpi 항체 조성물 |
JP2022529168A (ja) * | 2019-04-18 | 2022-06-17 | ヤンセン バイオテツク,インコーポレーテツド | シアル化糖タンパク質 |
TW202342522A (zh) | 2022-03-07 | 2023-11-01 | 日商武田藥品工業股份有限公司 | 臨床人類igg產品之親和層析生產 |
CN117069836A (zh) * | 2023-09-22 | 2023-11-17 | 武汉中生毓晋生物医药有限责任公司 | 一种抗人t细胞兔免疫球蛋白的制备方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE348942B (zh) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
US4136094A (en) * | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
DK166763C (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
DE3929411A1 (de) | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
US4892826A (en) | 1988-10-11 | 1990-01-09 | Abbott Laboratories | Process for the preparation of urokinase derivatives |
US4897465A (en) | 1988-10-12 | 1990-01-30 | Abbott Laboratories | Enrichment and concentration of proteins by ultrafiltration |
JP2871709B2 (ja) | 1988-11-21 | 1999-03-17 | 住友製薬株式会社 | 免疫グロブリンg結合活性を有する新規な蛋白質プロテインh、該蛋白質をコードする遺伝子及び該蛋白質の製造法 |
US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
AT402261B (de) | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
GB9418092D0 (en) * | 1994-09-08 | 1994-10-26 | Red Cross Found Cent Lab Blood | Organic compounds |
TW491855B (en) | 1996-08-07 | 2002-06-21 | Csl Ltd | Purification of immunoglobulins |
US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
AT405739B (de) | 1997-09-19 | 1999-11-25 | Immuno Ag | Verfahren zur reinigung von antithrombin iii |
US20020114802A1 (en) | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
US6281336B1 (en) * | 1998-06-09 | 2001-08-28 | Statens Serum Institut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
PT1084147E (pt) * | 1998-06-09 | 2005-01-31 | Statens Seruminstitut | Processo para producao de imunoglobulinas para administracao intravenosa e outros produtos de imunoglobulina |
AUPQ026799A0 (en) * | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
US20020098182A1 (en) | 2000-09-28 | 2002-07-25 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
FR2824568B1 (fr) | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
GB0113179D0 (en) | 2001-05-31 | 2001-07-25 | Novartis Ag | Organic compounds |
EP1463527A4 (en) | 2001-10-04 | 2005-05-11 | Protein Therapeutics Inc | USE OF GAMMAGLOBULIN FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES |
EP1664119A1 (en) | 2003-09-08 | 2006-06-07 | Medical Research Council | Method for the treatment or prophylaxis of tuberculosis |
WO2005073252A1 (en) | 2004-01-30 | 2005-08-11 | Suomen Punainen Risti Veripalvelu | Process for the manufacture of virus safe immunoglobulin |
JP5042817B2 (ja) | 2004-02-27 | 2012-10-03 | オクタフアルマ・アー・ゲー | ウイルス安全精製抗体調製物を提供する方法 |
US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
US7968293B2 (en) | 2007-08-13 | 2011-06-28 | Baxter International Inc. | IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
CN101279246B (zh) * | 2007-12-28 | 2011-07-27 | 华侨大学 | 一种嗜硫性磁性复合微球的制备方法和用此复合微球分离免疫球蛋白g的方法 |
ES2406029T3 (es) * | 2008-04-15 | 2013-06-05 | Grifols Therapeutics Inc. | Ultrafiltración/diafiltración en dos fases |
EP2435474A2 (en) * | 2009-05-27 | 2012-04-04 | Baxter International Inc | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
-
2010
- 2010-05-27 EP EP10722883A patent/EP2435474A2/en not_active Withdrawn
- 2010-05-27 WO PCT/US2010/036430 patent/WO2010138736A2/en active Application Filing
- 2010-05-27 CN CN201080032613.3A patent/CN102459331B/zh active Active
- 2010-05-27 JP JP2012513260A patent/JP5341252B2/ja active Active
- 2010-05-27 EA EA201171481A patent/EA023382B1/ru not_active IP Right Cessation
- 2010-05-27 AR ARP100101845A patent/AR076607A1/es active IP Right Grant
- 2010-05-27 AU AU2010253830A patent/AU2010253830B2/en active Active
- 2010-05-27 US US12/789,345 patent/US8546548B2/en active Active
- 2010-05-27 EP EP14162703.4A patent/EP2762492A3/en not_active Withdrawn
- 2010-05-27 EP EP19198667.8A patent/EP3708581A3/en active Pending
- 2010-05-27 SG SG2011087566A patent/SG176256A1/en unknown
- 2010-05-27 TW TW099117121A patent/TWI445714B/zh active
- 2010-05-27 MY MYPI2011005708A patent/MY157239A/en unknown
- 2010-05-27 MX MX2011012576A patent/MX2011012576A/es active IP Right Grant
- 2010-05-27 CA CA2763138A patent/CA2763138A1/en not_active Abandoned
- 2010-05-27 KR KR1020117030990A patent/KR101464032B1/ko active IP Right Grant
- 2010-05-27 BR BRPI1012082-3A patent/BRPI1012082B1/pt active IP Right Grant
-
2011
- 2011-11-25 CL CL2011002996A patent/CL2011002996A1/es unknown
- 2011-12-27 CO CO11179041A patent/CO6480954A2/es not_active Application Discontinuation
-
2013
- 2013-06-11 CL CL2013001673A patent/CL2013001673A1/es unknown
- 2013-07-24 US US13/949,565 patent/US9175068B2/en active Active
-
2015
- 2015-02-04 HK HK15101161.4A patent/HK1200843A1/zh unknown
- 2015-09-16 US US14/855,686 patent/US10125189B2/en active Active
-
2016
- 2016-05-30 AU AU2016203542A patent/AU2016203542B2/en active Active
-
2018
- 2018-01-23 AU AU2018200548A patent/AU2018200548B2/en active Active
- 2018-11-13 US US16/188,839 patent/US11242380B2/en active Active
-
2020
- 2020-06-25 AU AU2020204244A patent/AU2020204244B2/en active Active
-
2022
- 2022-01-31 US US17/589,519 patent/US20220153823A1/en active Pending
- 2022-09-07 AU AU2022228125A patent/AU2022228125B2/en active Active
-
2024
- 2024-05-29 AU AU2024203600A patent/AU2024203600A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200843A1 (zh) | 生產用於皮下使用的高度濃縮的免疫球蛋白製品的方法 | |
HK1260895A1 (zh) | 一種生產天然水晶著色劑的系統 | |
IL256533B (en) | A method for the production of inganol-3-englate | |
IL205121A0 (en) | A method for providing an application to plants | |
EP2596505A4 (en) | FIXING A LINE TO A SURFACE | |
PL2382040T3 (pl) | Sposób wytwarzania olefin | |
IL214470A (en) | A method for the production of a phenylacetamide compound | |
PL2576630T3 (pl) | Nowy sposób wytwarzania celulozy mikrokrystalicznej | |
PT2576629T (pt) | Um método novo para produzir microcelulose | |
PL2424657T3 (pl) | Sposób wytwarzania katalizatora | |
AP3169A (en) | A method of improved positioning | |
ZA201202726B (en) | A brewing method | |
PL2359996T3 (pl) | Sposób wytwarzania forniru | |
EP2690666A4 (en) | METHOD FOR PRODUCING A PHOTOELECTRIC CONVERTER ELEMENT | |
EP2537272A4 (en) | PROCESS FOR PROVIDING RECOMMENDATIONS FOR A USER | |
GB2481901B (en) | Production method for a microneedle arrangement | |
EP2440077A4 (en) | ALLOCATION OF A TAPE TO A TARGET OBJECT | |
HK1169080A1 (en) | Method for producing a visible covering | |
GB2501033B (en) | Method for connecting to a pipe | |
ZA201107567B (en) | Method for preparing a superplasticizer | |
ZA201105740B (en) | A brewing method | |
GB2471348B (en) | A method for producing sucralose-6-acylate | |
EP2690668A4 (en) | METHOD FOR PRODUCING A PHOTOELECTRIC CONVERTER ELEMENT | |
GB0909162D0 (en) | A method | |
ZA201300700B (en) | A brewing method |